FDA
-
-
-
-
-
-
-
DiaMedica closes $30.1 million private placement of common shares
-
-
-
-
-
-
-
DiaMedica Therapeutics (DMAC) Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
-
-
-
-
-
-
-
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
-
-
-
-
-
-
-
DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
-
-
-
-
-
-
-
DiaMedica Therapeutics (DMAC) Announces Appointment of Dr. Richard Kuntz to the Board of Directors
-
-
-
-
-
-
-
DiaMedica Therapeutics (DMAC) Issues Update on Paused ReMEDy2 Trial
-
322,899 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

